ID
13707
Description
Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00703820
Lien
https://clinicaltrials.gov/show/NCT00703820
Mots-clés
Versions (1)
- 29/02/2016 29/02/2016 -
Détendeur de droits
CC BY-NC 3.0
Téléchargé le
29 février 2016
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Acute Myeloid Leukemia NCT00703820
Eligibility Acute Myeloid Leukemia NCT00703820
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
down syndrome
Type de données
boolean
Alias
- UMLS CUI [1]
- C0013080
Description
acute promyelocytic leukemia (apl)
Type de données
boolean
Alias
- UMLS CUI [1]
- C0023487
Description
juvenile myelomonocytic leukemia (jmml)
Type de données
boolean
Alias
- UMLS CUI [1]
- C0349639
Description
fanconi anemia (fa)
Type de données
boolean
Alias
- UMLS CUI [1]
- C0015625
Description
kostmann syndrome
Type de données
boolean
Alias
- UMLS CUI [1]
- C1853118
Description
shwachman syndrome
Type de données
boolean
Alias
- UMLS CUI [1]
- C0272170
Description
other bone marrow failure syndromes
Type de données
boolean
Alias
- UMLS CUI [1]
- C2931245
Description
use of concomitant chemotherapy, radiation therapy, or immunotherapy other than as specified in the protocol.
Type de données
boolean
Alias
- UMLS CUI [1]
- C0392920
- UMLS CUI [2]
- C1522449
- UMLS CUI [3]
- C1531518
Description
use of investigational agents within 30 days or any anticancer therapy within 2 weeks before study entry with the exception of it therapy, hydroxyurea, or low-dose cytarabine as stated above. the patient must have recovered from all acute toxicities from any previous therapy.
Type de données
boolean
Alias
- UMLS CUI [1]
- C1875319
Description
systemic fungal, bacterial, viral, or other infection not controlled (defined as exhibiting ongoing signs/symptoms related to the infection and without improvement, despite appropriate antibiotics or other treatment).
Type de données
boolean
Alias
- UMLS CUI [1]
- C0009488
Description
pregnant or lactating patients.
Type de données
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Description
any significant concurrent disease, illness, or psychiatric disorder that would compromise patient safety or compliance, interfere with consent, study participation, follow up, or interpretation of study results.
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C1321605
- UMLS CUI [1,2]
- C0439801
- UMLS CUI [1,3]
- C0009488
Similar models
Eligibility Acute Myeloid Leukemia NCT00703820
- StudyEvent: Eligibility
C1522449 (UMLS CUI [2])
C1531518 (UMLS CUI [3])
C0006147 (UMLS CUI [2])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])